ArticleAddiction (Abingdon, England)2015
HIV epidemic among drug users in China: 1995-2011.
Article in Addiction (Abingdon, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.
- Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.The International journal on drug policy · 2019Pooled it
- Stigma towards people who use drugs: A case vignette study in methadone maintenance treatment clinics in China.The International journal on drug policy · 2019Trial
- An intervention trial targeting methadone maintenance treatment providers to improve clients' treatment retention in China.Drug and alcohol dependence · 2019Trial
- Mortality trends and epidemiological characteristics among people living with HIV in Huangshi, China: a time-series analysis (2004-2024).BMC public health · 2026Article
- Forecasting monthly AIDS incidence in China via LSTM-CNN parallel fusion: a comparative study of 10 predictive models.Frontiers in public health · 2026Article
- The origin and dissemination of HIV-1 subtype B on Hainan Island, South China, 2007-2024.BMC infectious diseases · 2025Article
- Study on Univariate Modeling and Prediction Methods Using Monthly HIV Incidence and Mortality Cases in China.HIV/AIDS (Auckland, N.Z.) · 2024Article
- The Effects of Online Health Information-Seeking Behavior on Sexually Transmitted Disease in China: Infodemiology Study of the Internet Search Queries.Journal of medical Internet research · 2023Article
- Sexual behaviour changes and HIV infection among men who have sex with men: evidence from an open cohort in China.BMJ open · 2022Article
- An exploratory transmission mode of HIV/AIDS among older people based on data from multiple sources in China.Scientific reports · 2022Article
- Drug users' awareness of and willingness to use HIV non-occupational post-exposure prophylaxis (nPEP) services in China: a mixed methods study.BMC infectious diseases · 2022Article
- Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China.BMC infectious diseases · 2021Article
- Epidemic of HIV infection among persons who inject drugs in mainland China: a series, cross-sectional study.Harm reduction journal · 2021Article
- A comparative study on the prediction of the BP artificial neural network model and the ARIMA model in the incidence of AIDS.BMC medical informatics and decision making · 2020Article
- HIV/AIDS Among Female Sex Workers in China: Epidemiology and Recent Prevention Strategies.Current HIV/AIDS reports · 2020Review
- HIV and HCV Infection Status Among Drug Users - China, 2010-2018.China CDC weekly · 2020Article
- Article
- History of the HIV Epidemic in China.Current HIV/AIDS reports · 2019Review
- Chinese herbal medicine for patients living with HIV in Guangxi province, China: an analysis of two registries.Scientific reports · 2019Article
- Trends in the Epidemiology of Sexually Transmitted Disease, Acquired Immune Deficiency Syndrome (AIDS), Gonorrhea, and Syphilis, in the 31 Provinces of Mainland China.Medical science monitor : international medical journal of experimental and clinical research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
aimTo describe trends in the HIV epidemic among drug users (DUs) in China from 1995 to 2011. DESIGN, SETTING AND
participantsData sets from China's national HIV/AIDS case reporting and sentinel surveillance systems as of December 2011 were used separately for descriptive analysis. MEASURES: Changes in the geographic distribution of the number of HIV cases and HIV prevalence among injecting drug users (IDUs) and non-IDUs were examined. We also analysed changes in HIV prevalence among the broader DU population, and drug use-related behaviours including types of drugs used, recent injecting and recent needle sharing in the context of the rapid scale-up of DU sentinel sites and national harm reduction programmes.
findingsThe HIV epidemic among China's DUs is still highly concentrated in five provinces. Here, HIV prevalence peaked at 30.3% [95% confidence interval (CI)=28.6, 32.1] among IDUs in 1999, and then gradually decreased to 10.9% (95% CI=10.6, 11.2) by 2011. We observed a rapid increase in the use of 'nightclub drugs' among DUs from 1.3% in 2004 to 24.4% in 2011. A decline in recent needle sharing among current IDU from 19.5% (95% CI=19.4, 19.6) in 2006 to 11.3% (95% CI=11.2, 11.4) in 2011 was found to be correlated with the rapid scale-up of methadone maintenance treatment (MMT; r(4)=-0.94, P=0.003) harm reduction efforts.
conclusionsWhile HIV prevalence and needle sharing among current injecting drug users in China have declined dramatically and are correlated with the scale-up of national harm reduction efforts, the recent, rapid increased use of 'nightclub drugs' presents a new challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.